Myomo shares are trading lower after the company announced that its request to the Centers for Medicare and Medicaid Services to classify MyoPro as a brace has been published for public comment.
Portfolio Pulse from Benzinga Newsdesk
Myomo announced that its request to the Centers for Medicare and Medicaid Services to classify MyoPro as a brace has been published for public comment. This news led to a decrease in Myomo's share price.
July 03, 2023 | 2:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Myomo's share price fell after the company announced its request to classify MyoPro as a brace has been published for public comment.
The announcement of Myomo's request being published for public comment indicates a regulatory process that could potentially impact the company's operations and revenue. This uncertainty may have led to the decrease in the company's share price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100